E. Signore

Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.

F. de Marinis, L. Travaini, M. Barberis, 2016, Clinical lung cancer.

Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers

F. de Marinis, G. Curigliano, C. Santoro, 2022, Clinical Lung Cancer.

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy

R. Sanctis, E. Cortesi, F. Longo, 2011, Supportive Care in Cancer.

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond

F. de Marinis, S. Ricciardi, A. Fulvi, 2011, Therapeutics and clinical risk management.

Safety and Efficacy of Oral Vinorelbine and Capecitabine Combination for Metastatic Breast Cancer

R. Sanctis, M. Basile, S. Quadrini, 2011, Journal of chemotherapy.

Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic development

G. Spitaleri, I. Attili, E. Signore, 2024, Cancer Treatment Reviews.